Cargando…
Deletion of soluble epoxide hydrolase suppressed chronic kidney disease-related vascular calcification by restoring Sirtuin 3 expression
Vascular calcification is common in chronic kidney disease (CKD) and contributes to cardiovascular disease (CVD) without any effective therapies available up to date. The expression of soluble epoxide hydrolase (sEH) is different in patients with and without vascular calcification. The present study...
Autores principales: | He, Wanbing, Huang, Jieping, Liu, Yang, Xie, Changming, Zhang, Kun, Zhu, Xinhong, Chen, Jie, Huang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542048/ https://www.ncbi.nlm.nih.gov/pubmed/34689162 http://dx.doi.org/10.1038/s41419-021-04283-6 |
Ejemplares similares
-
The Metabolism of Epoxyeicosatrienoic Acids by Soluble Epoxide Hydrolase Is Protective against the Development of Vascular Calcification
por: Varennes, Olivier, et al.
Publicado: (2020) -
Soluble Epoxide Hydrolase in Atherosclerosis
por: Wang, Yi-Xin Jim, et al.
Publicado: (2010) -
Genetic deletion of soluble epoxide hydrolase delays the progression of Alzheimer’s disease
por: Lee, Hsueh-Te, et al.
Publicado: (2019) -
Deletion of soluble epoxide hydrolase attenuates mice Hyperoxic acute lung injury
por: Liu, Li-Ping, et al.
Publicado: (2018) -
Soluble Epoxide Hydrolase Deletion Limits High-Fat Diet-Induced Inflammation
por: Wagner, Karen M., et al.
Publicado: (2021)